Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.
暂无分享，去创建一个
L. Schwartz | J. Meyerhardt | M. Bertagnolli | R. Goldberg | G. Abou-Alfa | A. El-Khoueiry | A. Venook | T. Bekaii-Saab | D. Niedzwiecki | J. Knox | T. Zemla | P. Kavan | J. Posey | L. Rajdev | A. Kaubisch | Q. Shi | E. O’Reilly | P. Lammers | B. Tan | R. Kelley | R. Goel | V. Tam | Jennifer Balletti | J. Suga | I. El Dika | Ryan I Potaracke | James H Harding | Tyler Zemla